ID

33521

Beschrijving

Study ID: 104297 Clinical Study ID: 104297 Study Title: An open study for a 2-year period to confirm the safety and immunogenicity of the candidate malaria vaccine RTS,S/AS02A in Mozambican children aged 1 to 4 years at the time of first vaccine dose. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00323622 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: SB257049 Trade Name: SB257049 Study Indication: Malaria

Trefwoorden

Versies (4)

1. 11-12-18 11-12-18 -
2. 06-06-19 06-06-19 -
3. 12-06-19 12-06-19 -
4. 27-09-21 27-09-21 -

Houder van rechten

GSK group of companies

Geüploaded op

11 december 2018

DOI

Voor een aanvraag inloggen.

Licentie